SARAH BYRD: Open Payments
NPI 1982057527 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 22 payments from 15 companies in 2025. Trend: 2023 $1,088 · 2024 $1,028 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: Bimzelx, DUPIXENT, Zoryve, LIBTAYO, COSENTYX, Rhapsido, TALTZ, REXULTI.
Industry payments across VA — which companies pay providers there.
